Menetelmä terapeuttisesti käyttökelpoisten 4-£4- tai 6-(trifluorimetyy li-2-pyridinyyli)|-1-piperatsinyylialkyylisubstituoitujen laktaamijohd annaisten valmistamiseksi

Menetelmä terapeuttisesti käyttökelpoisten 4-£4- tai 6-(trifluorimetyy li-2-pyridinyyli)|-1-piperatsinyylialkyylisubstituoitujen laktaamijohd annaisten valmistamiseksi

The invention relates to neuroleptic/antidepressant 4-[4- or 6-(trifluoromethyl)-2-pyridinyl]-1-piperazinylalkyl substituted lactam derivatives having the general structure of formula I: wherein one of the groups R1 and R2 is CF3, and the other is hydrogen or CF3; R3 is hydrogen or (1-4 C) alkyl; n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MONTEIL,ANDRE JEAN-CLAUDE, CARLIER,PATRICK, POISSON,CLAUDE, COMBOURIEU,MICHEL
Format: Patent
Sprache:fin ; swe
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to neuroleptic/antidepressant 4-[4- or 6-(trifluoromethyl)-2-pyridinyl]-1-piperazinylalkyl substituted lactam derivatives having the general structure of formula I: wherein one of the groups R1 and R2 is CF3, and the other is hydrogen or CF3; R3 is hydrogen or (1-4 C) alkyl; n is an integer from 4 to 5; and m is an integer from 1 to 2; or pharmaceutically acceptable salts thereof. The invention also includes processes for making the compounds and their salts.